Current treatment options have been limited to symptom control. Telitacicept, a novel fusion protein, and ianalumab, a ...

Results from the first randomized clinical trial in the United States to compare a sirolimus-eluting balloon (DEB) to a ...

A massive study of more than 2 million women has found a “statistically significant” risk of developing breast cancer with the use of a specific type of birth control pill.

For the last several quarters, Gilead Sciences’ earnings calls have been colored by anticipation for the launch of the California drugmaker's long-acting HIV pre-exposure prophylaxis (PrEP) option. | ...

A new wave of synthetic opioids, nitazenes, are causing a surge in overdose deaths globally. These potent drugs, developed ...

Libby Sweeney is a former credit cards editor for Forbes Advisor. Her previous experience writing and editing content for readers to better understand includes both the world of sports and data ...

In 2006, pseudoephedrine was moved behind the counter and limits were placed on how much a person could buy as a means to deter people from using it to make methamphetamine. Phenylephrine — the ...

The Renpho Eyeris 2 Massager helps alleviate my headaches and tired eyes, and I can stream music with it too. Follow ZDNET: Add us as a preferred source on Google.

Executives at the Minnesota-run medtech giant have banked on the high blood pressure-curbing renal denervation system to ...

A new device is being used by addiction treatment programs and in detention centers to help addicts get through opiate ...